{"Title": "A pragmatic, personalised approach to treatment initiation in Parkinson's disease", "Year": 2020, "Source": "Lancet Neurol.", "Volume": "19", "Issue": 5, "Art.No": null, "PageStart": 376, "PageEnd": 378, "CitedBy": 1, "DOI": "10.1016/S1474-4422(20)30065-X", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85083422310&origin=inward", "Abstract": null, "AuthorKeywords": null, "IndexKeywords": ["Antiparkinson Agents", "Humans", "Levodopa", "Parkinson Disease", "Precision Medicine"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 2, "EID": "2-s2.0-85083422310", "SubjectAreas": [["Neurology (clinical)", "MEDI", "2728"]], "AuthorData": {"7102634392": {"Name": "Schapira A.H.V.", "AuthorID": "7102634392", "AffiliationID": "60022148, 60019953", "AffiliationName": "Department of Clinical and Movement Neurosciences, University College London Queen Square Institute of Neurology, Royal Free Campus"}}}